Exosect receives further patent for Entomag platform technology

Exosect, a leading provider of enabling technologies has announced that it has received a US patent for its Entomag delivery platform bringing the total number of patents granted for this technology to seventeen.

Entomag is a ferrous micro powder with a lipid coating which can deliver a range of biological and synthetic active ingredients. The ferrous core enables the particle to be held in place to a suitable magnetic surface which means that this platform lends itself to the targeted delivery of active ingredients particularly for Lure & Kill systems for the control of crawling insects in the agricultural and public health sectors.

Martin Brown, CEO at Exosect comments, “Building a robust patent portfolio around our delivery platforms is key to maximising our licensing business model. To secure seventeen patent territories is a significant validation of this technology, the only key market we are waiting for is Brazil”.

Patent territories granted for Entomag platform includes USA, EU, Japan, Philippines, Indonesia, India, Israel, China Brazil, South Africa, GB, Italy, Spain, Turkey, France, Germany, Australia, Canada.